422 related articles for article (PubMed ID: 30238389)
1. Modeling Alzheimer's Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation.
Chang KH; Lee-Chen GJ; Huang CC; Lin JL; Chen YJ; Wei PC; Lo YS; Yao CF; Kuo MW; Chen CM
Mol Neurobiol; 2019 Jun; 56(6):3972-3983. PubMed ID: 30238389
[TBL] [Abstract][Full Text] [Related]
2. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic reticulum stress induces Alzheimer disease-like phenotypes in the neuron derived from the induced pluripotent stem cell with D678H mutation on amyloid precursor protein.
Devina T; Wong YH; Hsiao CW; Li YJ; Lien CC; Cheng IH
J Neurochem; 2022 Oct; 163(1):26-39. PubMed ID: 35943292
[TBL] [Abstract][Full Text] [Related]
4. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.
Israel MA; Yuan SH; Bardy C; Reyna SM; Mu Y; Herrera C; Hefferan MP; Van Gorp S; Nazor KL; Boscolo FS; Carson CT; Laurent LC; Marsala M; Gage FH; Remes AM; Koo EH; Goldstein LS
Nature; 2012 Jan; 482(7384):216-20. PubMed ID: 22278060
[TBL] [Abstract][Full Text] [Related]
5. The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons.
Muratore CR; Rice HC; Srikanth P; Callahan DG; Shin T; Benjamin LN; Walsh DM; Selkoe DJ; Young-Pearse TL
Hum Mol Genet; 2014 Jul; 23(13):3523-36. PubMed ID: 24524897
[TBL] [Abstract][Full Text] [Related]
6. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
[TBL] [Abstract][Full Text] [Related]
7. Assessing the therapeutic potential of Graptopetalum paraguayense on Alzheimer's disease using patient iPSC-derived neurons.
Wu PC; Fann MJ; Tran TT; Chen SC; Devina T; Cheng IH; Lien CC; Kao LS; Wang SJ; Fuh JL; Tzeng TT; Huang CY; Shiao YJ; Wong YH
Sci Rep; 2019 Dec; 9(1):19301. PubMed ID: 31848379
[TBL] [Abstract][Full Text] [Related]
8. N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons.
Chang CY; Chen SM; Lu HE; Lai SM; Lai PS; Shen PW; Chen PY; Shen CI; Harn HJ; Lin SZ; Hwang SM; Su HL
Sci Rep; 2015 Mar; 5():8744. PubMed ID: 25735452
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons.
Nieweg K; Andreyeva A; van Stegen B; Tanriöver G; Gottmann K
Cell Death Dis; 2015 Apr; 6(4):e1709. PubMed ID: 25837485
[TBL] [Abstract][Full Text] [Related]
10. The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease.
Sahlgren Bendtsen KM; Hall VJ
Cells; 2023 Jan; 12(3):. PubMed ID: 36766763
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
[TBL] [Abstract][Full Text] [Related]
12. Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability.
Muratore CR; Zhou C; Liao M; Fernandez MA; Taylor WM; Lagomarsino VN; Pearse RV; Rice HC; Negri JM; He A; Srikanth P; Callahan DG; Shin T; Zhou M; Bennett DA; Noggle S; Love JC; Selkoe DJ; Young-Pearse TL
Stem Cell Reports; 2017 Dec; 9(6):1868-1884. PubMed ID: 29153990
[TBL] [Abstract][Full Text] [Related]
13. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
14. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein
Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z
Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814
[TBL] [Abstract][Full Text] [Related]
15. Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model.
Long ZM; Zhao L; Jiang R; Wang KJ; Luo SF; Zheng M; Li XF; He GQ
CNS Neurosci Ther; 2015 Nov; 21(11):887-97. PubMed ID: 26385876
[TBL] [Abstract][Full Text] [Related]
16. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
Tackenberg C; Kulic L; Nitsch RM
PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
[TBL] [Abstract][Full Text] [Related]
17. Hyperphosphorylation of Tau induced by naturally secreted amyloid-β at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3β signaling pathway.
Tokutake T; Kasuga K; Yajima R; Sekine Y; Tezuka T; Nishizawa M; Ikeuchi T
J Biol Chem; 2012 Oct; 287(42):35222-35233. PubMed ID: 22910909
[TBL] [Abstract][Full Text] [Related]
18. A Unique GSK-3β inhibitor B10 Has a Direct Effect on Aβ, Targets Tau and Metal Dyshomeostasis, and Promotes Neuronal Neurite Outgrowth.
Shi XL; Yan N; Cui YJ; Liu ZP
Cells; 2020 Mar; 9(3):. PubMed ID: 32155989
[TBL] [Abstract][Full Text] [Related]
19. Indole Compound NC009-1 Augments APOE and TRKA in Alzheimer's Disease Cell and Mouse Models for Neuroprotection and Cognitive Improvement.
Chen YC; Chiu YJ; Lin CH; Hsu WC; Wu JL; Huang CH; Lin CW; Yao CF; Huang HJ; Lo YS; Chen CM; Wu YR; Chang KH; Lee-Chen GJ; Mei Hsieh-Li H
J Alzheimers Dis; 2019; 67(2):737-756. PubMed ID: 30689566
[TBL] [Abstract][Full Text] [Related]
20. Early pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutations.
Yang J; Zhao H; Ma Y; Shi G; Song J; Tang Y; Li S; Li T; Liu N; Tang F; Gu J; Zhang L; Zhang Z; Zhang X; Jin Y; Le W
Oncotarget; 2017 Jan; 8(5):7900-7913. PubMed ID: 27926491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
